Evaluation of chemerin, fetuin-A, interleukin-34, and interleukin-13 levels following periodontal treatment in diabetes mellitus
Clinical Oral Investigations · 2025
DOI: 10.1007/s00784-025-06539-3 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Clinical Oral Investigations, 2025. Verfasst von Nimet Gül Görgülü und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Faculty of Dentistry, Marmara University, 34854, Maltepe, Istanbul, Türkiye. Hauptthemen laut MEDLINE: alpha-2-HS-Glycoprotein, Chemokines, Diabetes Mellitus, Type 2, Intercellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVE: This cohort study investigated salivary and serum chemerin, fetuin-A, interleukin (IL)-34, and IL-13 changes in type 2 diabetes mellitus (T2DM) periodontitis following non-surgical periodontal therapy (NSPT). MATERIALS AND METHODS: A total of 110 participants were assigned to five groups (n = 22 each): non-periodontitis, non-periodontitis with T2DM, periodontitis (P), well-controlled T2DM periodontitis (WDM-P), and poorly controlled T2DM periodontitis (PDM-P). Periodontal parameters were recorded and biological samples collected at baseline and/or 3 months post-NSPT. Biomolecule levels were measured using ELISA. RESULTS: All periodontitis groups improved in periodontal parameters after 3 months (p < 0.05), but the proportion of patients who responded poorly to NSPT was higher in the PDM-P group compared to the P group (p = 0.026). HbA1c decreased in WDM-P and PDM-P groups at 3 months (p < 0.05). All salivary biomolecules were individually associated with periodontitis (p < 0.05), and their combined model distinguished periodontitis (AUC: 0.94). Serum chemerin and fetuin-A were linked to T2DM (p < 0.05), and their combination predicted T2DM (AUC: 0.91). After NSPT, salivary fetuin-A increased, salivary IL-13 decreased in three periodontitis groups (p < 0.05), whereas salivary chemerin, IL-34, and serum IL-34 reduced only in P group (p < 0.05). CONCLUSION: Salivary fetuin-A and IL-13 appear involved in periodontitis pathogenesis, while serum chemerin and fetuin-A in the T2DM. T2DM may hinder inflammation resolution, particularly involving chemerin and IL-34. CLINICAL RELEVANCE: The distinct biomolecule changes in systemically healthy versus T2DM periodontitis patients suggests that T2DM may impair inflammation resolution, underscoring the importance of personalized periodontal treatment strategies. This study was retrospectively registered on ClinicalTrials.gov (NCT06135532) on November 11, 2023.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology, Faculty of Dentistry, Marmara University, 34854, Maltepe, Istanbul, Türkiye.
- Esthetic Smile Academy Dental Clinic, Istanbul, Türkiye.
- Department of Periodontology, Faculty of Dentistry, Marmara University, 34854, Maltepe, Istanbul, Türkiye. basakdogan@marmara.edu.tr.
Zitieren
APA
Görgülü, N. G., Güngörmek, H. S., Kalkan, Y., & Doğan, B. (2025). Evaluation of chemerin, fetuin-A, interleukin-34, and interleukin-13 levels following periodontal treatment in diabetes mellitus. Clinical Oral Investigations. https://doi.org/10.1007/s00784-025-06539-3
Vancouver
Görgülü NG, Güngörmek HS, Kalkan Y, Doğan B. Evaluation of chemerin, fetuin-A, interleukin-34, and interleukin-13 levels following periodontal treatment in diabetes mellitus. Clinical Oral Investigations. 2025. doi:10.1007/s00784-025-06539-3
BibTeX
@article{Grgl2025,
author = {Görgülü, Nimet Gül and Güngörmek, Hatice Selin and Kalkan, Yaprak and Doğan, Başak},
title = {Evaluation of chemerin, fetuin-A, interleukin-34, and interleukin-13 levels following periodontal treatment in diabetes mellitus},
journal = {Clinical Oral Investigations},
year = {2025},
doi = {10.1007/s00784-025-06539-3}
}
EUVIMED